We are creating a new market under BLUE OCEAN Strategy by building worlds first vertically integrated platform for the CAR-T and STEM CELL THERAPY by the name DANEEN HEALTH HUB whereby we will provide treatment options to patients suffering from osteoarthritis and Blood cancer by “ first to market “ commercialized innovative CGT and Stem cell therapy products approved by CDSCO and DCGI in India at our partner clinics and hospitals through which patients can access and choose nearby Biotherapeutics centers where these biotherapies are available along with Doctors who will be treating the patients PAN INDIA and Globally starting with BIHAR .
Right now we are working on increasing the accessibility and affordibility below these two biotherapies in underserved regions of India .
1) StemOne :
Stempeucels® by Stempeutics PVT LTD is the first commercialized approved allogenic stem cell therapy product for treating CLI (Chronic Limb Ischemia ) and Knee OA (Osteoarthritis) in India commercialized and marketed by ALKEM LTD under brand StemOne.
Around 2000+ patients have been treated with this therapy since launch 2022 still there are 35 million active patients of osteoarthritis India alone and are going to be an increase by 40% of population affected in near future .
(b) NexCAR19 (Actalycabtagene autoleucel) :
IIT-B and Laurus Labs backed ImmunoACT Pvt Ltd have launched India's first CAR-T cell therapy, NexCAR19 (Actalycabtagene autoleucel), for the treatment of r/r B-cell lymphomas and leukemia from the Central Drugs Standard Control Organization (CDSCO).
Currently, Indians, who sought CAR-T therapy, had to import the treatment at a substantial cost of Rs 3-4 crore per patient or go abroad but now NexCAR19 is available at less than 1/10 th of that cost per patient in India .
ImmunoACT aims to expand its CAR-T therapy platform and bring down treatment costs even further.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Thane, Maharashtra 401107, In
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.daneenbio.com
- Keywords
- CELL AND GENE THERAPY, STEM CELL APPROVED PRODUCT IN INDIA, CELL & GENE THERAPY APPROVED PRODUCT IN INDIA.
- HQ
- Thane, Maharashtra
Daneen Biotherapeutics Questions
Daneen Biotherapeutics's website is https://www.daneenbio.com
Daneen Biotherapeutics's LinkedIn profile is https://in.linkedin.com/company/daneen-biotherapeutics
Daneen Biotherapeutics has
2 employees.
View email and phone details for 2
employees at Daneen Biotherapeutics.
Daneen Biotherapeutics's industry is
Pharmaceutical Manufacturing
Daneen Biotherapeutics's top competitors are
Bni Global,
Midwinter Solutions,
Lttrbx Technolabs,
Edenwell Therapeutics Pvt. Ltd,
Orifarm Clinical Trial Supplies,
Protalent Advisory,
Clientpharma,
Yourway,
Adianant Pharma Solutions,
Hibob.
Daneen Biotherapeutics's categories are Pharmaceutical Manufacturing
Daneen Biotherapeutics's founding year is 2023
